Dr Lal PathLabs reports higher Q3 profit on steady testing demand; dividend declared

Dr Lal PathLabs has approved a third interim dividend of ₹6 per equity share, which is 60% on a face value of ₹10 each, for the financial year 2024-25. The record date for the purpose of payment of the dividend will be February 5, 2025.